Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Current Report · Items 2.02, 7.01, 9.01 · 8-K

SiNtx Technologies, Inc.

SINTNASDAQEQUITYCurrent

Results of Operations and Financial Condition · Regulation FD Disclosure

Item 2.02 Results of Operations and Financial Condition. On October 1, 2026, SINTX Technologies, Inc. (the “Company”) issued a press release announcing preliminary, unaudited revenue for the fiscal quarter ended September 30, 2026 and providing an update regarding the Company’s previously announced revenue guidance.…

Filed Oct 1, 2026Accepted Oct 1, 2026, 9:05 AM EDTCIK 1269026Accession 0001493152-26-045278
Share

Company context

Headquartered in Salt Lake City, Utah, SINTX Technologies, Inc. (NASDAQ: SINT) is an advanced ceramics company that develops, manufactures, and commercializes silicon nitride biomaterials, composites, devices, and related technologies for medical and other high-value applications. SINTX’s technologies are supported by peer-reviewed research, a patent portfolio, U.S.-based manufacturing capabilities, and strategic industry relationships. The Company’s business includes proprietary biomaterials and medical device technologies, as well as contract manufacturing and other advanced ceramics opportunities. SINTX’s product portfolio includes the FDA-cleared SINAPTIC Foot & Ankle Implant System for reconstructive surgery.

Current securities

Historical securities (1)

Recent company filings

  1. Other EventsOct 9, 2026
  2. EFFECT filingAug 18, 2026
  3. SCHEDULE 13G - filed by Bleichroeder LP regarding Sintx Technologies, Inc.Aug 13, 2026
  4. Regulation FD Disclosure · Other EventsAug 13, 2026
  5. S-3 filingAug 13, 2026

Registered securities in this filing

SINTX Technologies, Inc. · 8-K · Filed 2026-10-01

As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.

Common Stock, par value $0.01 per share

Symbol
SINT
Exchange
NASDAQ
Classification
COMMON
Status
Current
Filing context

Context: AsOf2026-10-01

Dimensions: Not supplied

Accession 000149315226045278 · 1 registered-security cover member

Read the exact SEC filing ↗

Disclosure sections

Items 2.02, 7.01, 9.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 2.02Item 2.02 - Results of Operations
Item 2.02 Results of Operations and Financial Condition. On October 1, 2026, SINTX Technologies, Inc. (the “Company”) issued a press release announcing preliminary, unaudited revenue for the fiscal quarter ended September 30, 2026 and providing an update regarding the Company’s previously announced revenue guidance. The Company reported preliminary, unaudited revenue of approximately $2.2 million for the quarter ended September 30, 2026, of which approximately $2.1 million was derived from product sales. The preliminary financial information described above is based on information currently available to management and remains subject to completion of the Company’s quarter-end financial close and review procedures. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. Item 7.01. Regulation FD Disclosure. As described in the press release furnished as Exhibit 99.1, based on the preliminary quarterly revenue described under Item 2.02 above, the Company intends to deliver a Call Notice to the holders of its outstanding Class B Common Stock Purchase Warrants (the “Class B Warrants”) pursuant to the terms of the Class B Warrants. The Class B Warrants provide the Company with the right to call for exercise all or a portion of the outstanding Class B Warrants upon the Company reporting Quarterly Revenue, as defined in the Class B Warrants, of at least $2.0 million for a fiscal quarter in a qualifying Revenue Evidence Filing. The Company has determined that approximately $2.1 million of its revenue for the quarter ended September 30, 2026 constitutes Quarterly Revenue for purposes of the Class B Warrants. The press release also includes information regarding the Company’s fourth-quarter 2026 revenue outlook and certain business and operational developments. The information furnished pursuant to Items 2.02 and 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.
Filed exhibits (1)
EX-99.1 (by filename) ex99-1.htm

Exhibit 99.1 SINTX Announces Preliminary $2.2 Million in Q3 Revenue, Exceeding High-End Guidance Third-quarter revenue grows roughly 380% from Q2, driven by stronger-than-expected industrial sales to Fortune 500 customers; Company reiterates Q4 revenue guidance Revenue milestone also enables Company to call Class B warrants SALT LAKE CITY, Utah - October 1, 2026 - SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), a leader in advanced silicon nitride biomaterials and ceramics for medical and industrial applications, today announced preliminary, unaudited revenue of $2.2 million* for the third quarter ended September 30, 2026. The result exceeds the high end of the Company’s previously announced guidance of $0.9 million to $1.1 million, reflecting stronger-than-expected industrial ceramics sales, and is expected to result in narrower losses than previous quarters. Sales of industrial parts to aerospace subsidiaries of Fortune 500 companies accounted for the majority of third-quarter revenue. During the quarter, SINTX began shipments against the more than $3.2 million in contract manufacturing purchase orders announced in June, converting a portion of those orde…

Open exhibit ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.